Deutsche Bank AG Has $4.76 Million Stock Position in Balchem Co. (NASDAQ:BCPC)

Deutsche Bank AG reduced its stake in Balchem Co. (NASDAQ:BCPC) by 11.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,216 shares of the basic materials company’s stock after selling 3,933 shares during the period. Deutsche Bank AG owned 0.09% of Balchem worth $4,762,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in BCPC. Covestor Ltd boosted its holdings in Balchem by 93.8% during the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock worth $26,000 after buying an additional 76 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Balchem in the 4th quarter valued at approximately $29,000. Federated Hermes Inc. bought a new position in Balchem during the 4th quarter worth approximately $33,000. Venturi Wealth Management LLC acquired a new position in Balchem during the fourth quarter valued at approximately $95,000. Finally, Smartleaf Asset Management LLC increased its stake in Balchem by 230.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock valued at $106,000 after purchasing an additional 450 shares in the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. HC Wainwright set a $180.00 price target on shares of Balchem and gave the stock a “buy” rating in a research report on Monday, April 28th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Tuesday, May 13th. Finally, Sidoti raised Balchem to a “hold” rating in a research note on Tuesday, February 25th.

Balchem Price Performance

NASDAQ BCPC opened at $168.26 on Monday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. Balchem Co. has a 52-week low of $145.70 and a 52-week high of $186.03. The business has a 50 day simple moving average of $161.69 and a 200 day simple moving average of $166.34. The stock has a market cap of $5.49 billion, a price-to-earnings ratio of 42.81, a PEG ratio of 4.41 and a beta of 0.93.

Balchem (NASDAQ:BCPC) last issued its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by ($0.03). The company had revenue of $250.52 million for the quarter, compared to the consensus estimate of $245.70 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. The firm’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.03 EPS. Analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.